VisionPoint Advisory Group’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$703K Sell
24,585
-64,678
-72% -$2.05M 0.11% 199
2026
Q1
$2.81M Sell
89,263
-12,200
-12% -$384K 0.53% 44
2025
Q4
$2.99M Buy
101,463
+26,706
+36% +$742K 0.58% 44
2025
Q3
$1.89M Sell
74,757
-2,611
-3% -$63.6K 0.38% 73
2025
Q2
$1.86M Sell
77,368
-5,745
-7% -$133K 0.4% 68
2025
Q1
$1.9M Buy
83,113
+6,750
+9% +$163K 0.65% 46
2024
Q4
$1.92M Buy
76,363
+7,205
+10% +$183K 0.66% 47
2024
Q3
$1.72M Buy
+69,158
New +$2.05M 0.58% 45

Other funds holding RTO

VisionPoint Advisory Group's RTO Position: Q2 2026 in Review

VisionPoint Advisory Group reduced its Rentokil (RTO) stake by 72% in Q2 2026, selling an estimated $2.05M and leaving 24,585 shares worth $703K. The position accounts for 0.11% of the portfolio, ranked #199.

VisionPoint Advisory Group first reported a position in RTO in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.99M in Q4 2025. 23 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • VisionPoint Advisory Group held 24,585 shares of Rentokil worth $703K as of Q2 2026.
  • VisionPoint Advisory Group sold 64,678 Rentokil shares in Q2 2026, an estimated $2.05M.
  • Rentokil made up 0.11% of VisionPoint Advisory Group's portfolio in Q2 2026, its #199 holding.
  • VisionPoint Advisory Group first reported a position in Rentokil in Q3 2024 and has held it in 8 quarters since.
  • VisionPoint Advisory Group's Rentokil position peaked at $2.99M in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.